Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2065933
Reference Type
Journal Article
Title
Studies on the drug interaction of diltiazem. Part 1. Effects of co-administered drugs and dosing conditions on the bioavailability of diltiazem
Author(s)
Etoh, A; Kohno, J
Year
1983
Is Peer Reviewed?
1
Journal
Yakugaku Zasshi
ISSN:
0031-6903
EISSN:
1347-5231
Report Number
IPA/85/591089
Volume
Pharm
Issue
Yakugaku Zasshi
Page Numbers
426-433
Abstract
IPA COPYRIGHT: ASHP The effects of dipyridamole (I), propranolol, magnesium aluminum silicate, ethyl alcohol (II), food and sleep on the bioavailability of diltiazem (III) were studied in dogs and humans in single oral doses. In dogs, the absorption of III was delayed on the co-administration of food and antacid. Other bioavailability parameters such as plasma levels achieved and maximal blood concentration and area under the curve (AUC) were unchanged. Administration of II and I markedly increased the peak level and AUC of III. Biological half-lives were not altered as compared with III alone on any occasion. In healthy subjects, sleep caused a delay in III absorption. The results in dogs and humans were not parallel except time to reach the peak level. The relationship between the number of co-administered drugs and the steady-state plasma III levels was not significant.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity